Search
for
Sort by
Research 31–60 of 34
- Development and Evaluation of Nanoemulgel Loaded with Minoxidil
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Lymphoma Specialists Lament the Discontinuation of Underprescribed Bexxar
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Scanning electron microscopy of ibrutinib-induced hair shaft changes
- Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- Alopecia in patients treated with molecularly targeted anticancer therapies
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Dermatologic Adverse Events from Cancer Treatments
- Development and Evaluation of a Niosome-Integrated Microneedle System for Targeted Follicular Delivery of Ketoconazole in Alopecia Therapy
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Poster Abstracts
- Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Primary Vitreoretinal Lymphoma Presenting Solely with Asymptomatic Peripheral Drusenoid Lesions
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery
- PROTACs: A novel strategy for cancer drug discovery and development
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Malt1 Protease Is Critical in Maintaining Function of Regulatory T Cells and May Be a Therapeutic Target for Antitumor Immunity
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- Advancing Design Strategy of PROTACs for Cancer Therapy
- Refractory/relapse thrombocytopenia in a patient with Evans' syndrome successfully treated with zanubrutinib
- Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems